News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

LPC-001: Cancer Malignancy Longitudinal Project

Study Status:

Open for enrollment

Contact Information:

(956) 362-2384

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

This project is for the longitudinal collection of up to 125 newly diagnosed, treatment naïve cancer patients across three different indications: Colorectal cancer, Breast cancer and Lung Cancer. The expected time frame for this project is 5 years from the date of first enrollment. Specimen collection for this project will include plasma, buffy coat, tumor tissue FFPE blocks and NAT FFPE blocks.

Information: 

Principal Investigator
Dr. Sohail Rao
Co-PI
Odalys Salinas
Sponsor
Boca Biolistics
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram